FDA grants regular approval to sacituzumab govitecan for triple-negative breast cancer.On April 7, 2021, the Food and Drug Administration granted regular approval to sacituzumab govitecan (Trodelvy, Immunomedics Inc.) for patients with unresectable locally advanced or metastatic more...
Product Description Inlyta 5mg Tablet is an anti-cancer medicine used in the treatment of kidney cancer. Inlyta 5mg Tablet can be taken with or without food, but try to have it at the same time every day to get the most benefits. Your doctor will decide what dose is necessary andmore...
Product Description Inlyta 5mg Tablet is an anti-cancer medicine used in the treatment of kidney cancer. Inlyta 5mg Tablet can be taken with or without food, but try to have it at the same time every day to get the most benefits. Your doctor will decide what dose is necessary andmore...